ASKA Pharmaceutical Holdings in Numbers

Foundation

104years

（Founded in 1920）

Female Medicine Research

100years

* Over 100 years

Ob/Gyn* field

Top share in Japan

Leading Company

※In-house estimate

Thyroid field

Top share in Japan

95%

Consolidated Sales

60.4

billion yen

（FY2022）

ASKA Pharmaceutical 53.5 billion yen
（Pharamaceutical business）
ASKA Animal Health 6.6 billion yen
（Animal health business）
ASKA Pharma Medical 0.2 billion yen
（Testing business）

Number of Employees

764

（End of FY2023）

Major business sites

23

Including 1 international site

Operating profit margin

8.4％

（FY2022）

ROE（Return on Equity）

8.2％

（FY2022）

Dividend payout ratio

30％

（FY2024）
*A minimum annual dividend per
share of 30 yen

R&D expenses

4.2
billion yen

(FY2022)
*ASKA Pharmaceutical

Promotion of Women's advancement

Ratio of female
employees

32.9％

Ratio of female management positions

9.9％

Ratio of female management candidates

20.8％

（End of FY2022 in ASKA Pharmaceutical）

Initiatives to Promote the Advancement of Women

Ratio of male employees taking child care leave

94.7％

（FY2022 in ASKA Pharmaceutical)

Initiatives to Promote the Advancement of Women

Reduction rate of Total CO₂ Emissions

39％

* The rate in FY2022 compared with the rate in FY2013

Decarbonization Initiatives